Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF targeted therapy: A pooled secondary analysis of clinical trials.

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF targeted therapy: A pooled secondary analysis of clinical trials.'. Together they form a unique fingerprint.

    Medicine & Life Sciences